Follow-up testing in human serial sera from 11 patients who had developed HCC from chronic liver disease provided more sufficient evidence that autoantibody to GNAS might be considered as a serum biomarker for early detection of HCC. The gene discussed is GNAS; the disease is hepatocellular carcinoma.